Circular RNA | Host gene | Expression | Cancer type | Potential function | Mechanism | Reference |
---|---|---|---|---|---|---|
circ-EGFR | EGFR | Up | Glioblastoma | Promote cell proliferation and tumor growth | Formed a protein-complex, termed rtEGFR, which interacted with EGFR, maintained EGFR membrane localization and attenuated EGFR endocytosis and degradation | [21] |
circ-ENO1 | ENO1 | Up | Lung adenocarcinoma | Promote glycolysis, proliferation, migration and EMT; inhibit apoptosis | circ-ENO1/miR-22-3p/ENO1 | [22] |
circ-Amotl1 | Amotl1 | Up | Breast cancer; cervical cancer | Promote proliferation, migration, epithelial-mesenchymal transition (EMT) and tumor growth in vivo; decrease apoptosis | circ-Amotl1/c-myc (nuclear translocation and stability); Circ-Amotl1/miR-485-5P/Amotl1 | |
circCOL6A3 | COL6A3 | Up | Gastric cancer | Promote cell proliferation and migration; inhibit apoptosis | circCOL6A3/miR-3064-5p/COL6A3 | [31] |
circ_MMP2 | MMP2 | Up | Hepatocellular carcinoma | Promote metastasis of hepatocellular carcinoma in vitro and in vivo | circ_MMP2/miR-136-5p/MMP2 | [32] |
circDnmt1 | Dnmt1 | Up | Breast cancer | Promote proliferation and tumor xenograft growth; stimulate cellular autophagy; inhibit cellular senescence | circDnmt1/p53 and AUF1 (nuclear translocation and transcription)/Dnmt1 | [33] |
circXIAP (circ0005276) | XIAP | Up | Prostate cancer | Promote proliferation, migration and EMT | circXIAP/FUS/XIAP | [34] |
FECR1 | FLI1 | Up | Breast cancer | Promote tumor metastasis | FECR1/recruit TET1and DNMT1/FLI1 | [35] |
circ-CUX1 | CUX1 | Up | Neuroblastoma (NB) | Promote aerobic glycolysis, tumorigenesis, and aggressiveness of NB cells | circ-CUX1/EWSR1/MAZ/CUX1 | [36] |
circβ-catenin | β-catenin | Up | Liver cancer | Promote cell growth and migration and tumorigenesis and metastasis in vivo | β-catenin-370aa/GSK3β/β-catenin/Wnt/β-catenin pathway | [37] |
circFNTA | FNTA | Up | Bladder cancer | Promote cell invasion and cisplatin chemo-resistance; promote tumor growth and metastasis in vivo | AR/ADAR2/circFNTA/miR-370-3p/FNTA/KRAS | [38] |
circGFRA1 | GFRA1 | Up | Triple negative breast cancer | Promote cell proliferation and tumor growth in vivo; inhibit apoptosis | circGFRA1/miR-34a/GFRA1 | [39] |
circ-0075804 | E2F3 | Up | Retinoblastoma | Promote cell proliferation and suppress cell apoptosis | circ-0075804/HNPNPK/E2F3 (mRNA stability) | [40] |
circ-CCND1 (hsa_circ_0023303) | CCND1 | Up | Laryngeal squamous cell carcinoma | Promote cell proliferation in vitro and tumor growth in vivo | circ-CCND1/HuR and miR-646/CCND1 | [41] |
circ-MMP9 (hsa_circ_ 0001162) | MMP9 | Up | Oral squamous cell carcinoma | Promote migration and invasion and lung metastasis in vivo | circ-MMP9/AUF1 and miR-149/MMP9 | [42] |
hsa_circ_0047905 | SERPINB5 | Up | Gastric cancer | Promote cell proliferation and invasion | Not mentioned | [43] |
hsa_circ_0138960 | GDA | Up | Gastric cancer | Promote cell proliferation and invasion | Not mentioned | [43] |
hsa_circRNA7690-15 | GDA | Up | Gastric cancer | Promote cell proliferation and invasion | Not mentioned | [43] |
circ_0069765 | KIT | Up | Gastrointestinal stromal tumors | Promote tumor oncogenesis and progression | circ_0069765/miR-142-5p, miR-144-3p and miR-485-3p/KIT (regulatory network) | [44] |
circ_0084097 | PLAT | Up | Gastrointestinal stromal tumors | Promote tumor oncogenesis and progression | circ_0084097/miR-142-5p, miR-144-3p and miR-485-3p/PLAT (regulatory network) | [44] |
circ_0079471 | ETV1 | Up | Gastrointestinal stromal tumors | Promote tumor oncogenesis and progression | circ_0079471/miR-142-5p, miR-144-3p and miR-485-3p (regulatory network) | [44] |
circ_0001730 | EPHB4 | Up | Glioblastoma | Promote cell growth, invasion and tumor growth in vivo | SP1/EPHB4/circ_0001730/miR-326/Wnt7B/β-catenin pathway | [45] |
circCRIM1 | CRIM1 | Up | Ovarian cancer | Promote cell viability, migration, invasion and tumor growth in vivo; inhibit apoptosis | circCRIM1/miR-145-5p/CRIM1; encode 188aa protein; circCRIM1/miR-383-5p/ZEB2 | [46] |
circMETTL3 | METTL3 | Up | Breast cancer | Facilitate cell proliferation, migration, invasion and tumor growth in vivo | METTL3/circMETTL3/miR-31-5p/CDK1 | [47] |
circ-SIRT1 | SIRT1 | Up | Colorectal Cancer | Promote cell proliferation, invasion, and EMT | circ-SIRT1/EIF4A3/N-cadherin/vimentin | [48] |
hsa_circ_0003141 | UBAP2 | Up | Hepatocellular carcinoma | Promote cell proliferation, invasion and tumor growth in vivo; inhibit apoptosis | hsa_circ_0003141/miR-1827/UBAP2 | [49] |
hsa_circ_0006401 | col6a3 | Up | Colorectal cancer | Promote cell proliferation, migration, invasion, tumor growth and metastasis in vivo; inhibit apoptosis | Encode a novel 198-aa functional peptide to promote stability of the host gene col6a3 mRNA | [50] |
circ-SKA3 | SKA3 | Up | Medulloblastoma | Promote cell proliferation, migration and invasion | Not mentioned | [51] |
circ-DTL | DTL | Up | Medulloblastoma | Promote cell proliferation, migration and invasion | Not mentioned | [51] |
F-circEA1 | EML4-ALK1 | Up | Non-small cell lung cancer | Promote cell proliferation, migration, invasion and tumor growth in vivo; inhibit apoptosis; promote drug resistance to crizotinib | F-circEA1/EML4-ALK1/ALK downstream signaling pathway | [52] |
circMET | MET | Up | Colorectal cancer | Promote cell proliferation and growth | circMET/miR-410-3p/MET | [53] |
hsa_circ_0000069 | STIL | Up | Pancreatic cancer | Promote cell proliferation, migration, invasion and growth of xenograft pancreatic cancer tumors in vivo; inhibit apoptosis | hsa_circ_0000069/miR-144/STIL/ Gli1 | [54] |
hsa_circ_0062270 | CDC45 | Up | Melanoma | Promote the viability, proliferation, invasion and tumor growth in vivo; inhibit apoptosis | hsa_circ_0062270/EIF4A3/CDC45 | [55] |
circ-NOTCH1 | NOTCH1 | Up | Gastric cancer | Promote cell migration, invasion, stemness, tumor growth and metastasis in vivo | circ-NOTCH1/miR-449c-5p/MYC/NOTCH1 | [56] |
circZEB1 | ZEB1 | Up | Prostate cancer | Decrease radiosensitivity | TR4-mediated QKI/circZEB1/miR-141-3p/ZEB1 | [57] |
circ3323 | APP | Up | Bladder cancer | Promote cell invasion and migration | circ3323/miR-186-5p/APP | [58] |
F-circAE2 | AML1-ETO | Up | Leukemia cell | Promote cell proliferation in vitro and in vivo | F-circAE2/ENO-1 | [59] |
circBA9.3 | BCR-ABL1 | Up | Leukemia cell | Promote proliferation and inhibit apoptosis | Increase the protein expression of its host gene BCR-ABL1 | [60] |
F-circSRs (F-circSR1, F-circSR2) | SLC34A2-ROS1 | Up | Non-small cell lung cancer | Promote cell migration | F-circSRs/miR-150-5p, miR-194-3p and miR-515-5p | [61] |
F-circM9 | MLL-AF9 | Up | Leukemia cell | Promote cell proliferation and clonogenicity | Not mentioned | |
circ-Foxo3 | Foxo3 | Down | Non-small cell lung cancer (NSCLC); Breast cancer | Inhibit cell proliferation, migration and invasion of NSCLC cells; Inhibit proliferation and promote apoptosis of breast cancer cells | circ-Foxo3/miR-155/Foxo3; Foxo3P and circ-Foxo3/miR-22, miR-136*, miR-138, miR-149*, miR-433, miR-762, miR-3614–5p and miR-3622b–5p/Foxo3 | |
circ-ITCH | ITCH | Down | Lung cancer; esophageal squamous cell carcinoma; colorectal cancer; bladder cancer | Inhibit cell proliferation of lung cancer; Inhibit cell proliferation and tumor growth in vivo; Inhibit cell proliferation of colorectal cancer; Inhibit proliferation, migration, invasion and metastasis of bladder cancer both in vitro and in vivo | Cir-ITCH/miR-7 and miR-214/ITCH/Wnt/β-catenin pathway; cir-ITCH/miR-7, miR-17 and miR-214/ITCH/Dvl2/Wnt/β-catenin pathway; Cir-ITCH/miR-7 and miR-20a/ITCH/Wnt/β-catenin pathway/c-myc and cyclinD1; circ-ITCH/miR-17, miR-224/p21, PTEN | |
circ-FBXW7 | FBXW7 | Down | Glioblastoma; triple-negative breast cancer (TNBC) | Inhibit cell proliferation and the cell cycle of glioblastoma in vitro and in vivo; Inhibit cell proliferation and migration of TNBC, and tumor growth in vivo | FBXW7-185aa/USP28/c-Myc; circFBXW7/miR-197-3p/FBXW7 and FBXW7-185aa/USP28/FBXW7/c-Myc | |
circITGA7 | ITGA7 | Down | Colorectal cancer | Inhibit cell proliferation and migration in vitro and tumor growth in vivo | circITGA7/miR-370-3p/NF1/Ras pathway/RREB1/ITGA7 | [18] |
circZKSCAN1 | ZKSCAN1 | Down | Hepatocellular carcinoma | Inhibit cell proliferation, migration, invasion and tumor growth in vivo | Not mentioned | [19] |
ciRS-7/CDR1-AS | CDR1 | Down | Glioblastoma multiforme | Inhibit cell proliferation | MiR-671-5p/CDR1-AS/CDR1/VSNL1 | [65] |
circ0006916 | HOMER1 | Down | Lung cancer | Inhibit cell proliferation | TNRC6A/circ0006916/miR-522-3p/PH domain and PHLPP1 | [66] |
circHIPK3 | HIPK3 | Down | Bladder cancer | Inhibit migration, invasion, and angiogenesis of bladder cancer cells in vitro and suppress bladder cancer growth and metastasis in vivo | circHIPK3/miR-558/heparinase (HPSE) | [67] |
circ-SHPRH (hsa_circ_0001649) | SHPRH | Down | Glioblastoma; hepatocellular carcinoma (HCC) | Inhibit cell proliferation of glioblastoma and tumor growth in vivo; Inhibit proliferation and migration of HCC in vitro and in vivo | circ-SHPRH/SHPRH-146aa/SHPRH/PCNA; circ-0001649/miR-127-5p, miR-612 and miR-4688/SHPRH | |
circ-AKT3 | AKT3 | Down | Glioblastoma | Inhibit cell proliferation, radiation resistance and in vivo tumorigenicity of glioblastoma cells | circ-AKT3/AKT3-174aa/AKT-thr308 phosphorylation/sequential activation by p-PDK1 | [70] |
circ-EPB41L5 | EPB41L5 | Down | Glioblastoma | Inhibit cell proliferation, migration, invasion and the growth of brain xenograft tumors of glioma cells | circ-EPB41L5/miR-19a/EPB41L5/ RhoC/p-AKT | [71] |
hsa_circ_0099329 | PPFIA2 | Down | Glioblastoma | Not mentioned | Not Mentioned | [72] |
circKCNN2 | KCNN2 | Down | Hepatocellular carcinoma | Inhibit HCC cell proliferation, colony formation, migration, and tumor formation in a mouse model | circKCNN2/miR-520c-3p/ methyl-DNA-binding domain protein 2 (MBD2)/FGFR4 | [73] |
circKEAP1 | KEAP1 | Down | Lung adenocarcinoma | Inhibit cell proliferation, migration, invasion and tumor growth in vivo | circKEAP1/miR-141-3p/ KEAP1/NRF2 | [74] |
circ_0018414 | DKK1 | Down | Lung adenocarcinoma | Inhibit cell proliferation, stemness and tumor growth in vivo; promote cell apoptosis | circ_0018414/ miR-6807-3p/DKK1/ Wnt/β-catenin | [75] |
circASS1 | ASS1 | Down | Breast cancer | Inhibit invasion and migration | circASS1/ miR-4443/ASS1 | [76] |
circ-PTEN (hsa_circ_0094342) | PTEN | Down | Non-small cell lung cancer | Inhibit cell proliferation and tumor growth in vivo | DHX9/circ-PTEN/miR-155 and miR-330-3p/PTEN/PI3K/AKT pathway | [77] |
hsa_circ_0036722 | RHGG | Down | Laryngeal squamous cell carcinoma | Inhibit cell proliferation in vitro | hsa_circ_0036722/miR-1248/ RHCG | [78] |
circ_LARP4 | LARP4 | Down | Ovarian cancer | Inhibit cell proliferation, invasion and migration | circ_LARP4/miR-513b-5p/LARP4 | [79] |